Search 

Trading in Pharmaceuticals and Medical Devices and Medical consumable products in United Arab Emirated

A CAP, CLIA And AABB certified clinical lab specialized in genetic and molecular diagnosis

Medprin focuses on RD and sales and marketing of implantable medical devices with products in general surgery and neurosurgery. Current Medprin is actively looking for promising startups /team with matching technology/products that Medprin can both invests financially and develops long term partnership.

MedSci Healthcare was established in 2002 with the creation of Bioon.com, with headquarters in Shanghai and internationally in the U.S. We are committed to be the bridge between China and the U.S. healthcare. This is done by connecting Chinese healthcare professionals (HCPs) with U.S. resources and vice versa.
The company has done projects with major companies such as: Pfizer, Harvard Medical School, AstraZeneca, GSK, Abbott, Johnson & Johnson, Takeda, Novartis, Medtronic and many more. We have also worked with organizations such as the China Cardiovascular Association (CCA), Chinese Medical Doctor Association (CMDA) and more.
MedSci is a digital academic platform, scientific publishing support and multichannel marketing (MCM) organization. We use the term Academic Promotion Organization (APO). We use scientific writers, doctors & researcher scientists and commercialization experts to develop customized strategy & implementation to reach each organization’s goals.

Medical Device Company

MedWorld Advisors is an international M&A Services Firm. We represent medical technology companies from the US, EU and Israel that want to enter the China market. We facilitate licensing, commercialization and acquisition deals between our clients and larger companies / investors in China. We are based in Boston in the U.S. We also have an operation in Hong Kong to help facilitate deals, as helpful.

After 35 years of development, the company has established an industry pattern integrating science, industry and trade led by international trade, supported by the pharmaceutical industry, and linked by pharmaceutical business, covering the whole industrial chain including R&D, production, distribution, logistics, import and export trade, academic promotion, and technical services.

Mend Biotech’s full name is Mend Biotechnology Incorporation, and its English name is Mend Biotech Inc. ( MBT). It is a multinational research institution focusing on the field of regenerative medicine to treat various skeletal-related diseases. The founding team consists of Professors and Scientists in Cedars-Sinai Medical center, UCLA and Harvard University and the kick school of medicine in USC, and the CEO of a multinational biotechnology company. In June 2020, MBT settled in CHENGDU TianFu international Bio-town as a key project introduced by Chengdu High-tech zone government. MBT received 13.5 million Chinese yuan in seed round investment by Mr. chen keming, chairman of keming noodle industry, a listed company in China. A follow on angel round is expected to generate an investment of 40 million. GMP and cGMP lab are currently under construction in both China and US.

Biopharmaceutical